BRAF and neoplasm: Consistent with the observation that multiple metabolites showed increased levels in BRAF-mutant PTC tumor samples (Supplementary Fig. S4b), the controlled IHH4 cells also showed improved levels in a series of metabolites, especially PE and PC species, compared to the BRAF knockdown cells (Supplementary Fig. S10g).